Despite the availability of pulmonary arterial hypertension (PAH)-targeted therapeutic options over the past twenty years, there is general consensus around shortcomings with regards to PAH diagnosis and management.
Despite the availability of pulmonary arterial hypertension (PAH)-targeted therapeutic options over the past twenty years, there is general consensus around shortcomings with regards to PAH diagnosis and management.
New research in the International Journal of Nursing Studies examines the effect of an Early Warning Score-guided proactive rapid response team model on the frequency of unplanned intra-hospital escalations in care.
Researchers recently published findings based on secondary analysis of a study, HF-ACTION, examining the impact of structured aerobic exercise on patients with long-term heart failure with reduced ejection fraction (HFrEF). The secondary analysis applied the association of baseline chronic liver disease (CLD) on the benefits of structured aerobic exercise for the patients.
Cardiovascular disease is a known determinant of morbidity and mortality in patients undergoing kidney transplantation, which is the commonly chosen treatment for patients with end-stage kidney disease. Researchers for this study sought to examine the rate of major cardiovascular adverse events (MACEs), in the context of an aging transplant population on waitlists, higher diabetic populations and increasing dialysis pre-transplantation, specifically for the perioperative kidney transplantation period.
Below are two novel thoracic aorta trials being conducted at Baylor Scott & White – The Heart Hospital Plano. These trials leverage our multi-disciplinary team approach, which brings Cardiothoracic and Vascular surgeons together in our TAA clinic for collaborative, simultaneous visits with each patient. This approach has proven time and again to better inform decisions surrounding patient care plans and help produce stronger outcomes.